<p>NewEdge Advisors LLC 在最近向證券交易委員會提交的 13F 表格中表示，在第二季度將其在美敦力 PLC (NYSE:MDT - 免費報告) 的持倉削減了 37.4%。該公司在季度內出售了 81,417 股後，持有 136,203 股這家醫療科技公司的股票。截至其最近向證券交易委員會提交的文件，美敦力的持股價值為 11,873,000 美元。</p>
<ul>
<li>美敦力股票找到支撐——現在正在獲得動能</li>
</ul>
<p>其他機構投資者也對該公司的股份進行了增持或減持。Gilbert &amp; Cook Inc. 在第二季度將其在美敦力的股份增加了 1.9%。Gilbert &amp; Cook Inc. 目前持有 6,103 股這家醫療科技公司的股票，價值 532,000 美元，此前在上個季度增持了 114 股。Red Spruce Capital LLC 在第二季度將其在美敦力的持股增加了 0.5%。Red Spruce Capital LLC 目前持有 23,707 股這家醫療科技公司的股票，價值 2,067,000 美元，此前在該期間增持了 118 股。Certior Financial Group LLC 在第一季度將其在美敦力的持倉增加了 3.7%。Certior Financial Group LLC 目前持有 3,450 股這家醫療科技公司的股票，價值 310,000 美元，此前在上個季度增持了 122 股。Cary Street Partners Investment Advisory LLC 在第二季度將其在美敦力的持股增加了 6.0%。Cary Street Partners Investment Advisory LLC 目前持有 2,191 股這家醫療科技公司的股票，價值 191,000 美元，此前在該期間增持了 124 股。最後，PrairieView Partners LLC 在第二季度將其在美敦力的股份增加了 3.6%。PrairieView Partners LLC 目前持有 3,726 股這家醫療科技公司的股票，價值 324,000 美元，此前在上個季度增持了 128 股。對沖基金和其他機構投資者持有該公司 82.06% 的股份。</p>
<h2>分析師設定新目標價</h2>
<p>MDT 最近成為多份分析師報告的主題。高盛集團在 11 月 19 日的報告中將美敦力的目標價設定為 111.00 美元，並給予該公司 “中性” 評級。巴克萊在 11 月 20 日的報告中將美敦力的目標價從 109.00 美元上調至 111.00 美元，並給予該股票 “增持” 評級。阿古斯在 8 月 26 日的研究報告中將美敦力的目標價從 105.00 美元上調至 115.00 美元，並給予該公司 “買入” 評級。桑福德·C·伯恩斯坦在 11 月 19 日的研究報告中將美敦力的目標價設定為 111.00 美元。最後，斯蒂費爾·尼古拉斯在 10 月 9 日的報告中將美敦力的目標價從 90.00 美元上調至 105.00 美元，並給予該股票 “持有” 評級。一位研究分析師給予該股票 “強烈買入” 評級，十三位給予 “買入” 評級，十二位給予 “持有” 評級。根據 MarketBeat 的數據，美敦力目前的共識評級為 “適度買入”，共識目標價為 110.44 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
<p><strong>獲取我們最新的 MDT 股票報告</strong></p>
<h2>美敦力股票下跌 1.0%</h2>
<p>美敦力股票週五開盤價為 99.77 美元。該公司的債務與股本比率為 0.57，流動比率為 2.42，速動比率為 1.80。該公司的 50 日移動平均線為 97.23 美元，200 日移動平均線為 92.66 美元。該公司的市值為 1,279.1 億美元，市盈率為 26.89，PEG 比率為 2.65，貝塔值為 0.71。美敦力 PLC 的一年低點為 79.29 美元，一年高點為 106.33 美元。</p>
<ul>
<li>美敦力：收入投資者的機會變得更好</li>
</ul>
<p>美敦力 (NYSE:MDT - 獲取免費報告) 最近在 11 月 18 日星期二發佈了季度財報。這家醫療科技公司報告季度每股收益為 1.36 美元，超出市場共識預期的 1.31 美元，超出幅度為 0.05 美元。美敦力的淨利潤率為 13.71%，股本回報率為 14.86%。該公司在本季度的收入為 89.6 億美元，而分析師預期為 88.6 億美元。在去年同期，該公司每股收益為 1.26 美元。美敦力的季度收入同比增長 6.6%。美敦力已將其 2026 財年的指導目標設定為 5.620-5.660 每股收益。整體來看，賣方分析師預計美敦力 PLC 本財年將發佈 5.46 美元的每股收益。</p>
<h2>美敦力分紅公告</h2>
<p>該公司最近還披露了一項季度分紅，將於 1 月 16 日星期五支付。12 月 26 日的登記投資者將獲得每股 0.71 美元的分紅。這相當於每年 2.84 美元的分紅，收益率為 2.8%。該分紅的除息日期為 12 月 26 日。美敦力的分紅支付比率 (DPR) 為 76.55%。</p>
<h2>關於美敦力</h2>
<p>(免費報告)</p>
<p>美敦力 plc 開發、製造和銷售基於設備的醫療療法，面向全球的醫療系統、醫生、臨牀醫生和患者。其心血管產品組合提供可植入的心臟起搏器、心臟復律除顫器和心臟再同步治療設備；心臟消融產品；可植入心臟監測系統；TYRX 產品；以及遠程監測和以患者為中心的軟件。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過美敦力</li>
<li>如何計算退休收入：MarketBeat 的計算器</li>
<li>2026 年需避免的三隻最近被下調的股票</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>芯片熱潮迴歸：三隻有望大幅上漲的股票</li>
<li>股票拆分，真的會影響投資者嗎？</li>
<li>甲骨文股票遭重創：為何其 AI 管道可能推動 2026 年的反彈</li>
</ul>
<p><strong>想知道其他對沖基金持有 MDT 的情況嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Medtronic PLC (NYSE:MDT - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Medtronic 嗎？</h2>
<p>在考慮 Medtronic 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Medtronic 並不在名單上。</p>
<p>雖然 Medtronic 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

美敦力

<p>NewEdge Advisors LLC 在第二季度減少了對美敦力（Medtronic PLC）的持股，減持幅度為 37.4%，出售了 81,417 股。該公司目前持有 136,203 股，市值為 1187 萬美元。其他機構投資者也調整了在美敦力的持倉。分析師設定了新的價格目標，普遍評級為 “適度買入”，目標價格為 110.44 美元。美敦力的股票開盤價為 99.77 美元，市值為 1279.1 億美元。該公司報告第二季度每股收益為 1.36 美元，超出預期，營收為 89.6 億美元，同比增長 6.6%</p>

<p>NewEdge Advisors LLC trimmed its position in Medtronic PLC (NYSE:MDT - Free Report) by 37.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 136,203 shares of the medical technology company's stock after selling 81,417 shares during the quarter. NewEdge Advisors LLC's holdings in Medtronic were worth $11,873,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>NewEdge Advisors LLC 在最近向證券交易委員會提交的 13F 表格中表示，在第二季度將其在美敦力 PLC (NYSE:MDT - 免費報告) 的持倉削減了 37.4%。該公司在季度內出售了 81,417 股後，持有 136,203 股這家醫療科技公司的股票。截至其最近向證券交易委員會提交的文件，美敦力的持股價值為 11,873,000 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到支撐——現在正在獲得動能</li>
</ul>
</div><p>Other institutional investors have also added to or reduced their stakes in the company. Gilbert &amp; Cook Inc. raised its stake in shares of Medtronic by 1.9% during the second quarter. Gilbert &amp; Cook Inc. now owns 6,103 shares of the medical technology company's stock valued at $532,000 after acquiring an additional 114 shares during the last quarter. Red Spruce Capital LLC increased its holdings in Medtronic by 0.5% during the 2nd quarter. Red Spruce Capital LLC now owns 23,707 shares of the medical technology company's stock valued at $2,067,000 after purchasing an additional 118 shares during the period. Certior Financial Group LLC raised its position in Medtronic by 3.7% during the 1st quarter. Certior Financial Group LLC now owns 3,450 shares of the medical technology company's stock valued at $310,000 after purchasing an additional 122 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its holdings in Medtronic by 6.0% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 2,191 shares of the medical technology company's stock worth $191,000 after buying an additional 124 shares during the period. Finally, PrairieView Partners LLC grew its position in shares of Medtronic by 3.6% in the 2nd quarter. PrairieView Partners LLC now owns 3,726 shares of the medical technology company's stock worth $324,000 after buying an additional 128 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>其他機構投資者也對該公司的股份進行了增持或減持。Gilbert &amp; Cook Inc. 在第二季度將其在美敦力的股份增加了 1.9%。Gilbert &amp; Cook Inc. 目前持有 6,103 股這家醫療科技公司的股票，價值 532,000 美元，此前在上個季度增持了 114 股。Red Spruce Capital LLC 在第二季度將其在美敦力的持股增加了 0.5%。Red Spruce Capital LLC 目前持有 23,707 股這家醫療科技公司的股票，價值 2,067,000 美元，此前在該期間增持了 118 股。Certior Financial Group LLC 在第一季度將其在美敦力的持倉增加了 3.7%。Certior Financial Group LLC 目前持有 3,450 股這家醫療科技公司的股票，價值 310,000 美元，此前在上個季度增持了 122 股。Cary Street Partners Investment Advisory LLC 在第二季度將其在美敦力的持股增加了 6.0%。Cary Street Partners Investment Advisory LLC 目前持有 2,191 股這家醫療科技公司的股票，價值 191,000 美元，此前在該期間增持了 124 股。最後，PrairieView Partners LLC 在第二季度將其在美敦力的股份增加了 3.6%。PrairieView Partners LLC 目前持有 3,726 股這家醫療科技公司的股票，價值 324,000 美元，此前在上個季度增持了 128 股。對沖基金和其他機構投資者持有該公司 82.06% 的股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>MDT has been the subject of a number of recent analyst reports. The Goldman Sachs Group set a $111.00 target price on Medtronic and gave the company a &#34;neutral&#34; rating in a report on Wednesday, November 19th. Barclays upped their price objective on shares of Medtronic from $109.00 to $111.00 and gave the stock an &#34;overweight&#34; rating in a report on Thursday, November 20th. Argus lifted their target price on shares of Medtronic from $105.00 to $115.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, August 26th. Sanford C. Bernstein set a $111.00 price target on shares of Medtronic in a research report on Wednesday, November 19th. Finally, Stifel Nicolaus raised their price objective on shares of Medtronic from $90.00 to $105.00 and gave the stock a &#34;hold&#34; rating in a report on Thursday, October 9th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company's stock. According to MarketBeat, Medtronic presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $110.44.</p>
<div class="lb-trans"><p>MDT 最近成為多份分析師報告的主題。高盛集團在 11 月 19 日的報告中將美敦力的目標價設定為 111.00 美元，並給予該公司 “中性” 評級。巴克萊在 11 月 20 日的報告中將美敦力的目標價從 109.00 美元上調至 111.00 美元，並給予該股票 “增持” 評級。阿古斯在 8 月 26 日的研究報告中將美敦力的目標價從 105.00 美元上調至 115.00 美元，並給予該公司 “買入” 評級。桑福德·C·伯恩斯坦在 11 月 19 日的研究報告中將美敦力的目標價設定為 111.00 美元。最後，斯蒂費爾·尼古拉斯在 10 月 9 日的報告中將美敦力的目標價從 90.00 美元上調至 105.00 美元，並給予該股票 “持有” 評級。一位研究分析師給予該股票 “強烈買入” 評級，十三位給予 “買入” 評級，十二位給予 “持有” 評級。根據 MarketBeat 的數據，美敦力目前的共識評級為 “適度買入”，共識目標價為 110.44 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on MDT</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 MDT 股票報告</strong></p>
</div><h2>Medtronic Stock Down 1.0%</h2>
<div class="lb-trans"><h2>美敦力股票下跌 1.0%</h2>
</div><p>Shares of Medtronic stock opened at $99.77 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. The company has a 50-day moving average of $97.23 and a 200 day moving average of $92.66. The firm has a market cap of $127.91 billion, a price-to-earnings ratio of 26.89, a PEG ratio of 2.65 and a beta of 0.71. Medtronic PLC has a 1 year low of $79.29 and a 1 year high of $106.33.</p>
<div class="lb-trans"><p>美敦力股票週五開盤價為 99.77 美元。該公司的債務與股本比率為 0.57，流動比率為 2.42，速動比率為 1.80。該公司的 50 日移動平均線為 97.23 美元，200 日移動平均線為 92.66 美元。該公司的市值為 1,279.1 億美元，市盈率為 26.89，PEG 比率為 2.65，貝塔值為 0.71。美敦力 PLC 的一年低點為 79.29 美元，一年高點為 106.33 美元。</p>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投資者的機會變得更好</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last posted its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, topping the consensus estimate of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The business had revenue of $8.96 billion for the quarter, compared to analyst estimates of $8.86 billion. During the same quarter in the previous year, the firm posted $1.26 earnings per share. Medtronic's quarterly revenue was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, sell-side analysts anticipate that Medtronic PLC will post 5.46 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>美敦力 (NYSE:MDT - 獲取免費報告) 最近在 11 月 18 日星期二發佈了季度財報。這家醫療科技公司報告季度每股收益為 1.36 美元，超出市場共識預期的 1.31 美元，超出幅度為 0.05 美元。美敦力的淨利潤率為 13.71%，股本回報率為 14.86%。該公司在本季度的收入為 89.6 億美元，而分析師預期為 88.6 億美元。在去年同期，該公司每股收益為 1.26 美元。美敦力的季度收入同比增長 6.6%。美敦力已將其 2026 財年的指導目標設定為 5.620-5.660 每股收益。整體來看，賣方分析師預計美敦力 PLC 本財年將發佈 5.46 美元的每股收益。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>美敦力分紅公告</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic's dividend payout ratio (DPR) is 76.55%.</p>
<div class="lb-trans"><p>該公司最近還披露了一項季度分紅，將於 1 月 16 日星期五支付。12 月 26 日的登記投資者將獲得每股 0.71 美元的分紅。這相當於每年 2.84 美元的分紅，收益率為 2.8%。該分紅的除息日期為 12 月 26 日。美敦力的分紅支付比率 (DPR) 為 76.55%。</p>
</div><h2>About Medtronic</h2>
<div class="lb-trans"><h2>關於美敦力</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力 plc 開發、製造和銷售基於設備的醫療療法，面向全球的醫療系統、醫生、臨牀醫生和患者。其心血管產品組合提供可植入的心臟起搏器、心臟復律除顫器和心臟再同步治療設備；心臟消融產品；可植入心臟監測系統；TYRX 產品；以及遠程監測和以患者為中心的軟件。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>How to Calculate Retirement Income: MarketBeat’s Calculator</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
<li>Stock Splits, Do They Really Impact Investors?</li>
<li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過美敦力</li>
<li>如何計算退休收入：MarketBeat 的計算器</li>
<li>2026 年需避免的三隻最近被下調的股票</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>芯片熱潮迴歸：三隻有望大幅上漲的股票</li>
<li>股票拆分，真的會影響投資者嗎？</li>
<li>甲骨文股票遭重創：為何其 AI 管道可能推動 2026 年的反彈</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他對沖基金持有 MDT 的情況嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Medtronic PLC (NYSE:MDT - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Medtronic 嗎？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Medtronic 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Medtronic 並不在名單上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Medtronic 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

NewEdge Advisors LLC 出售了 81,417 股美敦力公司（Medtronic PLC）的股票，代碼為$MDT